Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers

CD44, a therapeutic target for metastasising tumours

(2010) Véronique Orian-Rousseau   EUROPEAN JOURNAL OF CANCER

Efficacy and safety of imatinib mesylate (Gleevec®) and immunohistochemical expression of c-Kit and PDGFR-β in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus

(2010) Warner K. Huh et al.   GYNECOLOGIC ONCOLOGY

Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma

(2009) Gloria S. Huang et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Hormone receptor expression in uterine sarcomas: Prognostic and therapeutic roles

(2009) Y.J. Ioffe et al.   GYNECOLOGIC ONCOLOGY

Uterine sarcomas: A review

(2009) Emanuela D'Angelo et al.   GYNECOLOGIC ONCOLOGY

Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients

(2009) Vera M Abeler et al.   HISTOPATHOLOGY

Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system

(2009) Emanuela D'Angelo et al.   HUMAN PATHOLOGY

Immunohistochemical Analysis of P16, P53, and Ki-67 Expression in Uterine Smooth Muscle Tumors

(2009) Longwen Chen et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: Experience in Helsinki University Central Hospital 1990–2001

(2008) Riitta Koivisto-Korander et al.   GYNECOLOGIC ONCOLOGY